Ragweed Allergy
📧 Sign up to get email alerts when something new happens for Ragweed Allergy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-02-14Clinical Trial Update: Threshold Concentrations for Ragweed and Birch Pollen in Seasonal Allergic Rhinitis [NA]
A clinical trial evaluating threshold pollen concentrations for ragweed and birch pollen in seasonal allergic rhinitis has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-23Clinical Trial Update: Ragweed-SPIRE Follow-On Study
Circassia Limited reports that the Ragweed-SPIRE follow-on clinical trial has completed. The study targeted rhinoconjunctivitis and ragweed …
-
CLINICAL_TRIALS trial_result · 2012-05-17Clinical Trial Update: ToleroMune Ragweed Follow up Study
Update on a completed follow-up clinical trial of ToleroMune Ragweed for ragweed allergy with rhinoconjunctivitis.
-
CLINICAL_TRIALS trial_result · 2011-10-07Clinical Trial Update: Identification of Potential Biomarkers of Response to Peptide Immunotherapy for Ragweed Allergy [Phase 2]
Phase 2 trial update identifying potential biomarkers of response to peptide immunotherapy for ragweed allergy.
-
CLINICAL_TRIALS trial_result · 2011-10-07Clinical Trial Update: ToleroMune Ragweed Exposure Chamber Study [Phase 2]
A Phase 2 clinical trial update for ToleroMune in ragweed allergy has completed, using an exposure chamber to assess outcomes.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-11-10Clinical Trial Update: Safety of ToleroMune Ragweed to Treat Ragweed Allergy in Ragweed Allergic Subjects With Rhinoconjunctivitis [Phase 2]
Phase 2 trial evaluating the safety of ToleroMune Ragweed in ragweed-allergic individuals with rhinoconjunctivitis has completed.
-
CLINICAL_TRIALS trial_result · 2010-06-17Clinical Trial Update: Investigation of Efficacy and Safety of Ragweed MATAMPL, Pollinex-R and Placebo in Patients With Ragweed Allergy [Phase 2]
Phase 2 clinical trial evaluating Ragweed MATAMPL, Pollinex-R, and placebo for efficacy and safety in ragweed allergy has completed.